88Trust
Verified
🔍 Web Verified🔍 Search Verified
ProPublicaonBluesky3d ago
The FDA won’t tell Americans where their generic drugs are made, so ProPublica did it instead.
Use information from your prescription label to locate the factory and see if the plant has a history of inspection violations.
Trust Metrics
95
90
80
80
Claim Accuracy95%
Source Quality90%
Framing & Tone80%
Context80%
Analysis Summary
This is accurate reporting. The FDA does restrict manufacturing location transparency—it cites confidential commercial information, and while companies must disclose locations when applying to sell generics, the FDA does not publish that information. ProPublica built Rx Inspector in response, linking over 80% of generic drugs to their manufacturing facilities using data it sued the FDA for. The tool works and is live. One note: the post's framing suggests the FDA is unusually secretive, which is true, but skips context—the FDA says it protects the information as confidential commercial data, and the tool itself is incomplete since the data isn't perfect and some locations may be outdated.
Claims Analysis (3)
“The FDA won't tell Americans where their generic drugs are made”
The FDA will not release manufacturing location information through FOIA, citing confidential commercial information.
“ProPublica created a tool to locate generic drug factories”
ProPublica launched Rx Inspector, providing where generics come from and factory track records.
“The tool allows users to see if plants have inspection violations”
The database shows the facility that manufactured generic drugs and any FDA inspection reports.
Was this analysis helpful?
Try ClearFeed free →